Ambient particulate matter (PM) exacerbates allergic airway diseases. Our previous study showed that diesel exhaust particles, the main constituents in urban PM, enhance airway hyperresponsivness in mice. In addition, health effects of PM with a diameter of less than 100 nm, called nanoparticles, have been reported, and we have also demonstrated that carbon nanoparticles exacerbate antigen-related airway inflammation. The present study investigates the effects of pulmonary exposure to two sizes of carbon nanoparticles on lung physiology and lung expression of Muc5ac in the presence or absence of antigen in mice. Nanoparticles alone or ovalbumin (OVA) alone moderately enhanced cholinergic airway reactivity, as assessed by total respiratory system resistance (R) and Newtonian resistance (R). In the nanoparticle + OVA groups, all the parameters for lung responsiveness, such as R, compliance, elastance, R n , tissue damping, and tissue elastance, were worse than those in the vehicle group, the corresponding nanoparticle groups or the OVA group. The lung mRNA level for Muc5ac was significantly higher in the OVA group than in the vehicle group, and further increased in the nanoparticle + OVA groups than in the OVA or the nanoparticle groups. These data suggest that carbon nanoparticles can enhance lung hyperresponsiveness, especially in the presence of antigen. The effects may be mediated, at least partly, through the enhanced lung expression of Muc5ac.
airway inflammation as compared with larger particle exposure (8) (9) . It is thought that because nanoparticles can penetrate deeply into the respiratory tract and have a larger surface area than particles with larger size, they cause a greater inflammatory response and more tissue damage (10) (11) .
Bronchial asthma is characterized by airway inflammation and reversible airflow obstruction with hyperresponsiveness. Nano (ultrafine) particles (PM and carbon black) reportedly exaggerate antigenrelated airway inflammation in vivo (mice and rats) (12) (13) (14) . Further, we previously reported that pulmonary exposure to two sizes of nanoparticles aggravates antigen-related airway inflammation characterized by infiltration of eosinophils and lymphocytes around the airway and an increase in replaced goblet cells in the bronchial epithelium, and that the adverse effects tended overall to be more prominent with smaller particles than with larger ones (15) . Lung hyperresponsiveness, including the excessive constriction of airways in response to a variety of non-specific stimuli, is another cardinal hallmark of asthma (16) . Asthmatic subjects are frequently hyperresponsive to contractile agonists such as methacholine (MCh). Although there have been a few studies that investigated the effects of nanoparticles on airway physiology (17) (18) using enhanced pause (Penh), there are no reported studies examining them applying both the singlecompartment model and the constant-phase model. Moreover, there have been no studies elucidating the size effects of nanoparticles on lung reactivity. MUC5AC (whose murine homologue is Muc5ac) has been identified as a mucin producing gene (19) .
The present study was, therefore, designed to determine the effects of two sizes of nanoparticles on the cholinergic lung physiology in the presence or absence of antigen and on the local expression of Muc5ac in order to supplement the mechanisms of nanoparticle-facilitation on the model.
MATERIALS AND METHODS

Animals
Male ICR mice 6 to 7 wk of age and weighing 29 to 33 g (Japan Clea Co., Tokyo, Japan) were used in all experiments. They were fed a commercial diet (Japan Clea Co.) and given water ad libitum. The mice were housed in an animal facility that was maintained at 24 to 26°C with 55 to 75% humidity and a 12-h light/dark cycle.
Study Protocol
The mice were divided into six experimental groups as described in our previous study [shown as Fig. I in Inoue et al. (15) ]. The vehicle group received phosphatebuffered saline (PBS), pH 7.4 (Nissui Pharmaceutical Co., Tokyo, Japan), containing 0.05% Tween 80 (Nakalai Tesque, Kyoto, Japan) once a week for 6 wk. The ovalbumin (OVA) group received I /-lg of OVA (Sigma Chemical, St. Louis, MO) dissolved in the same vehicle every 2 wk for 6 wk. The nanoparticle groups received 50 ug of each size of carbon nanoparticles (14 nm: PrinteX 90 or 56 nm: PrinteX 25, degussa, Dusseldorf, Germany) suspended in the same vehicle every week for 6 wk. The nanoparticle + OVA groups received combined treatment in the same protocol as the OVA and the nanoparticle groups, respectively. The surface area of the 14 nm nanoparticles was 300 m 2/g and that of 56 nm nanoparticles was 45 m 2/g. The size of each particle was quantified using a JEM-20 I0 transmission electron microscope (TEM; JEOL, Tokyo, Japan). Nanoparticles were autoclaved at 250°C for 2 hours before use. The suspension was sonicated for 3 min using an Ultrasonic disrupter (UD-20 I; Tomy Seiko, Tokyo, Japan). In each group, vehicle, OVA, nanoparticles, or nanoparticles + OVA was dissolved in O.I-ml aliquots, and inoculated by the intratracheal route through a polyethylene tube under anesthesia with 4% halothane (Hoechst, Japan, Tokyo, Japan). The animals were studied 24 h after the last intratracheal administration. The study protocol followed the National Institutes of Health guidelines for the experimental use of animals. All animal studies were approved by the Institutional Review Board of the National Institute for Environmental Studies.
Analysis oflung function
Assessment of cholinergic airway/lung constrictor responsiveness was done with a computer-controlled small-animal ventilator (FlexiVent; Scireq, Montreal, Canada) as previously described (20) (21) (22) (23) . In brief, the mice were anesthetized with 0.1 ml per 109 body weight of 40 mg/ml ketamine hydrochloride given intraperitoneally. Anesthesia was maintained by supplemental administration of 30% of the initial dose at '"'-'25-min intervals, as required. Mice were tracheostomised with a 5 mm section of metallic tubing and ventilated (FlexiVent) at 180 b.min' with a tidal volume of 10 ml/kg and a positive end expiratory pressure of 3 cmll.O.
Both the single-compartment model (using the snap shot method) and the constant-phase model (using the forced oscillation technique [FaT] method) of respiratory mechanics were applied to assess airway responses and lung function to methacholine. For the singlecompartment model, total respiratory system resistance (R), elastance (E), and compliance (C) were determined essentially as described previously (20) (21) . For the constant-phase model, Newtonian resistance (R n ) , tissue damping (G), and tissue elastance (H) were determined as described previously (20, 23) . All data points were determined by the FlexiVent software (version 5.0) by using multiple linear regression to fit each data point to the single-compartment or the constant-phase model, as appropriate. The lung volume history of the mice was standardised prior to measurement of lung mechanics using two deep inflations. P and V data were generated by applying a 2 s sine wave volume perturbation (SW) with an amplitude of 0.2 ml and a frequency of 2.5 Hz. After 5 min of regular mechanical ventilation, the SW perturbation was applied three times and the average was taken to generate a baseline measurement. The respiratory system input impedance (Zrs) was measured during periods of apnea using a 3 s signal containing 19 mutually prime sinusoidal frequencies ranging from 0.25 to 19.625 Hz; these maneuvers generated data that were fitted to the single-compartment or the constant-phase compartment models, respectively. The averages of these measurements for each mouse served as its baseline values. Following the acquisition of baseline data, airway responsiveness to aerosolized methacholine (MCh: 0.125 to 25 mg/mL saline; delivered by ultrasonic nebulizer) was assessed using both the snap shot and FOT methods. Aerosols were delivered for lOs with ventilation at 180 b.min' with a tidal volume of 4 ml/kg, after which the snap shot and the FOT methods were applied consecutively every 6 s for 5 min. Peak responses during each 5-min period were determined, and only values with a coefficient of determination of 0.95 or greater were used (n = 8 in each group).
Extraction of mRNA and reverse transcription (RT) -polymerase chain reaction (peR) analysis
In another experiment, total RNAs in the lung were extracted with ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. cDNA synthesis was conducted according to the manufacturer's protocol. The quantitation of mRNA expression was carried out by real-time RT-PCR using the ABI Prism 7000 Sequence Detection System (TaqMan, Perkin-Elmer Corp., Foster City, CA) according to the manufacturer's instructions. cDNAs were amplified using the thermal profile of 50°C for 2 minutes then 95°C for 10 minutes, followed by up to 40 cycles of 95°C for 15 seconds and 60°C for I minute. Specific primers and probes were obtained from Applied Biosystems. The sequences of Muc5ac and 18S rRNA, which were purchased from Perkin-Elmer, were not disclosed by the manufacturer. The quantitation of gene expression was derived from the cycle number at which the fluorescent signal crossed a threshold in the exponential phase of the PCR reaction using the standard curve method according to the manufacturer's protocol. The relative quantitation of mRNA was normalized to an endogenous control gene (18S rRNA; n = 6-8 in each group).
Statistical analysis
Data were reported as mean±standard deviation (SD). Differences were analyzed by Kruskal-Wallis test followed by Mann-Whitney U test using the SPSS 8.0 statistical package for Windows (Chicago, IL). Values of P < 0.05 or P < 0.01 were considered significant.
RESULTS
Effects of nanoparticles on lung function in the presence or absence ofantigen
To evaluate the effects of nanoparticles on MCh responsiveness, we investigated R (Fig. IA) , E ( Fig. I B) , C (Fig. IC) , Rn (Fig. ID) , G (Fig. IE) , and H (Fig. IF) in six groups of mice 24 h after the last intratracheal instillation. R was higher in the nanoparticle groups or the OVA group than in the vehicle group (N. S.) (Fig. IA) . The value was significantly higher in the nanoparticle + OVAgroups than in the vehicle group (P < 0.05), nanoparticle group (P < 0.05 for the 56 nm nanoparticle + OVA group), or the OVA group (P < 0.05 for the 56 nm nanoparticle + OVA group). E was higher in the 14 nm nanoparticle group or the nanoparticle + OVA groups than in the other groups (N. S.). C was lower in the nanoparticle groups or the OVA group than in the vehicle group (N. S.) and was significantly lower in the nanoparticle + OVA groups than in the vehicle group (P < 0.05 for the 56 nm nanoparticle + OVA group), the nanoparticle groups, or the OVA group. R n was higher in the nanoparticle groups or the OVA group than in the vehicle group (N. S.) (Fig. ID) . The value was significantly higher in the nanoparticle + OVA groups than in the vehicle, the nanoparticle groups, or the OVA group (P < 0.05). G was higher in the 56 nm nanoparticle + OVA group than in the other groups (P < 0.05 vs. the vehicle group). H was higher in the 14 nm nanoparticle group or the OVA group than in the vehicle group (N. S.) and even higher in the nanoparticle + OVA groups than in the other groups (N. S.).
DISCUSSION
Results are shown as mean ± SD (n = 6-8 in each group). •P < 0.05 versus vehicle. .. P < 0.01 versus vehicle, S P < 0.01 versus nanoparticles, # P < 0.01 versus OVA Table I . Six groups of mice were intratracheally inoculated with vehicle. nanoparticles (NP), ovalbumin (OVA), or the combination ofNP and 0 VA for 6 wk. Lungs were removed 24 h after the last intratracheal administration.
Our previous study demonstrated that nanoparticles repeatedly administered by the intratracheal route deteriorate antigen-related airway inflammation in mice (15) . The deterioration was concomitant with amplified lung expression of Th2 cytokines such as interleukin (IL)-5, IL-6, and IL-13 and chemokines such as eotaxin, macrophage inflammatory protein-1a, macrophage chemoattractant protein-I, RANTES [regulated on activation and normal T cell expressed and secreted], and TARC [thymus and activation-regulated chemokine] (15, 24) . Also, nanoparticles exhibited potent adjuvant activity for antigen-specific IgGI and IgE production (15) . The present study extends the previous one to show that nanoparticles also facilitate antigen-related lung hyperresponsiveness to MCh.
Previous studies have shown that airway exposure to ambient-derived particles worsens airway hyperresponsiveness in allergic or non-allergic animals (25) (26) (27) (28) . In addition, it has been established that DEP aggravate airway hyperresponsiveness related to antigen in vivo (28) (29) . Furthermore, our recent work demonstrated that carboneous particulate component in DEP, rather than the organic chemical one, can predominantly enhance the antigenrelated lung hyperresponsiveness using the same apparatus (FlexiVent) as the present one (manuscript in submission). Therefore, combustion-derived particles themselves may have important roles in the deterioration of airway hyperresponsiveness in the presence or absence of antigen. Also, some previous studies demonstrated that exposure to nanoparticles (ultrafine particles) exacerbates allergic airway disease in vivo (13, IS, (17) (18) . However, there have been few studies investigating the effects of nanoparticles on airway physiology in the model. Barrett et al. examined the effects of inhaled carbon nanoparticles on airway resistance in ragweedsensitized dogs, and found no significant effects (18) . In contrast, Alessandrini and colleagues explored the effects of inhaled nanoparticles at different phases on asthma in mice and found that inhalation of elemental carbon nanoparticles 24 h before antigen (OVA) challenge had the most profound enhancing effects on the sensitized mice (17) . These contradictory results may be due to differences ofthe study protocol and/or animal species. On the other hand, all ofthese studies used Penh, which is derived from an unrestricted barometric plethysmograph, to measure changes in lung physiology. As Penh cannot differentiate constriction in the airways from changes in the tissue compartment of the lungs, it is difficult for Penh to show the true physiological responses (30) (31) . Furthermore, there have been no studies to address the size effects of nanoparticles on the cardinal manifestations ofasthma. Therefore, our present study examined, for the first time, the size effects of nanoparticles on detailed lung functions using FOT in the presence or absence of antigen and showed that nanoparticles could enhance lung 
Effects of nanoparticles on local expression of Muc5ac
To explore the effects of nanoparticles on the expression of Muc5ac, we quantitated mRNA levels for Muc5ac in the lung 24 h after the last intratracheal instillation (Table I ). The level for Muc5ac was significantly higher in the OVA group than in the vehicle group (P < 0.05). The levels were even higher in the nanoparticle + OVA groups than in the vehicle group (P < 0.01), nanoparticle groups (P < 0.01), or the OVA group (P < 0.01 for the 14 nm nanoparticle + OVA group). hyperresponsiveness.
The precise mechanisms underlying the enhancing effects of nanoparticles on the airway hyperresponsiveness remain unknown. Our previous report on nanoparticle-facilitation on the asthma model included enhancing effects on epithelial desquamation with goblet cell hyperplasia (15) . Of the 19 human mucin genes identified to date, MUC5AC is considered one of the master genes for secreted mucin of the bronchial epithelium (19) . Goblet cell hyperplasia in the airway plays a role in airway remodeling with impaired airway physiology (19) . Furthermore, it has been implicated that airway hyperresponsiveness in asthma is related to epithelial desquamation, at least partly, through loss of epithelium-derived relaxing factor (32) (33) . In the present study, lung expression level of Muc5ac was higher in the nanoparticle + OVA groups than in the OVA group and paralleled the degree of goblet cell hyperplasia in our previous study (15) . Thus, it is likely that this enhanced expression of Muc5ac contributes to augmented goblet cell hyperplasia and consequent cholinergic airway hyperreactivity, in particular related to antigen, in the model.
Although the lung has a well-developed antioxidant system (34) , overproduction of reactive oxygen species (ROS) or depression of the protective systems results in epithelial cell damage, cell shedding, and airway hyperreactivity (35) (36) . In vivo studies have indicated that ROS contribute to airway hyperresponsiveness by increasing vagal tone resulting from damage of oxidant-sensitivẽ -adrenergic receptors as well as decreasing mucociliary clearance (37) (38) . Regarding this, our previous work using the same protocol as the present one has demonstrated that formation of 8-hydroxy-2' -deoxyguanosine, a marker of DNA damage by oxidative stress, is moderately induced by nanoparticles as compared with vehicle, and is markedly enhanced by nanoparticles plus antigen as compared with antigen alone (I5). Thus, the enhancement of lung reactivity to MCh induced by nanoparticles, especially in the presence of antigen, may be mediated in part through the induction of ROS.
Our detailed analyses of lung functions revealed that antigen exposure tended to worsen the values of E, C, G, and H in the present study. Also, the values were further worsened in the nanoparticle + OVA groups. The changes in these parameters positively reflect the functional consequences of airway remodeling with stiffening and narrowing of the lung (39) (40) . Furthermore, the local expression of Muc5ac and goblet cell hyperplasia were enhanced in the nanoparticle + OVA groups compared to the other groups. Taken together, our findings suggest that nanoparticles could be important for antigenrelated airway remodeling.
In our previous studies, the enhancing effects of nanoparticles on airway (lung) inflammation and local expression of cytokines and chemokines related to antigen were more prominent with 14 nm nanoparticles than with 56 nm nanoparticles with overall trends (I5, 24). However, no difference in lung hyperresponsiveness between the two sizes of nanoparticles was found in the present study. Rather, the hyperresponsiveness tended to be worse in the 56 nm nanoparticle + OVA group than in the 14 nm nanoparticle + OVA group, especially with respect to Rand R n • This phenomenon could be explained by the fact that the augmented lung expression ofIL-13 and the goblet cell hyperplasia found in the 56 nm nanoparticle + OVA group were sufficient to amplify lung hyperresponsiveness. Alternatively, other pivotal factors related to the reactivity, including vagotonia-synpathicotonia systems, epithelial growth factor (EGF)-EGF receptor signaling, and/ or anaphylaxins (C3a, C5a), might be influenced independent of particle size, especially when the particles are less than 100 nm. The resolution of these discrepancies will require further studies.
In conclusion, the present study has provided evidence that pulmonary exposure to carbon nanoparticles can enhance antigen-related lung hyperresponsiveness. The effects may be mediated, at least in part, through enhanced lung expression of Muc5ac. However, no size dependency of the enhancing effect was found. Based on the present and previous findings (I5), it appears that nanoparticles aggravate pivotal manifestations of asthma such as airway (lung) inflammation and hyperreactivity.
